This is the authors' abstract. We don't add key points for this paper.
Histiocytic sarcoma (HS) is a malignant tumor composed of proliferating cells of histiocytic origin. True HS is exceedingly rare, particularly in pediatric patients. These tumors are frequently aggressive, and outcome for patients with HS has traditionally been poor. There is currently no consensus on the optimal management of these tumors, with the literature consisting largely of case reports and small case series utilizing a wide variety of therapies. We describe a case of HS in an 8-year-old female who was successfully treated with an abbreviated leukemia chemotherapy regimen.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Heath et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: